Your session is about to expire
← Back to Search
Palliative Care for Parkinson's Disease (ACT for PD Trial)
ACT for PD Trial Summary
This trial examines how palliative care improves quality of life and reduces burden for those living with Parkinson's and their caregivers.
ACT for PD Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ACT for PD Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with severe cognitive impairment.I am currently receiving palliative care or hospice services.I need moderate to high support for my symptoms or stress from illness.I have been diagnosed with Parkinson's disease or a similar disorder.I am between 20 and 100 years old.I have another illness that may need palliative care, like cancer spread.I need immediate care to manage my cancer symptoms.
- Group 1: Palliative care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there a cutoff age for enrollment in this experiment?
"Applicants hoping to participate in this medical trial must be between the ages of 20 and 100. Additionally, there are 38 trials for those under 18 and 515 additional ones available to people aged 65 or older."
Are new participants being welcomed into the experiment?
"As referenced on clinicaltrials.gov, the recruitment phase for this trial has been completed. Originally posted November 4th 2022 and last modified October 28th 2022, it is not presently in search of candidates; however, there are 522 other medical studies that remain active in recruiting at present."
Do I satisfy the prerequisites for participation in this medical experiment?
"A cohort of 100 individuals dealing with Parkinson's disease, ranging in age from 20 to 100 years old, are eligible for enrollment. In addition, these patients must have been diagnosed with a related PDRD (Multiple System Atrophy/ Corticobasal Degeneration/ Progressive Supranuclear Palsy/ Lewy Body Dementia) and demonstrate moderate-to-high palliative needs based on the PC NAT assessment tool."
Share this study with friends
Copy Link
Messenger